Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Autoimmune Diseases × Mastectomy, Segmental × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Rectal Neoplasms 3 Triple Negative Breast Neoplasms 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplastic Cells, Circulating 1 Margins of Excision 1 Local Recurrence of Malignant Tumor of Breast 1 Breast Image Scale Index for Self Esteem Evaluation 1 Breast Carcinoma In Situ 1 BRCA1/2 Mutation 1 Autoimmune Diseases 1 Adenocarcinoma of Lung 1

Interventions

Data Collection 3 Blood Specimen Collection 2 human papillomavirus vaccine, L1 type 16, 18 1 apremilast 1 Watchful Waiting 1 Surveys and Questionnaires 1 Standard of Care 1 Practice Guidelines as Topic 1 Phlebotomy 1 Methods 1 Mastectomy, Segmental 1 Mammaplasty 1 Interviews as Topic 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Educational Status 1 Early Intervention, Educational 1 Dietary Fiber 1 CT-P13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05400954 2023-04-28

AREOLA-B

The Netherlands Cancer Institute

15,000 enrolled

Autoimmune Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡